首页> 外国专利> Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment

Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment

机译:具有生物活性的天然存在的多胺类似物,药物组合物和治疗方法

摘要

Polyamines having the formula: chemistry chemdraw filechemistry mol file;or a salt thereof with a pharmaceutically acceptable acid wherein: ;R1-R6 may be the same or different and are alkyl, aryl, aryl alkyl, cycloalkyl, optionally having an alkyl chain interrupted by at least one etheric oxygen atom, or hydrogen; ;N1, N2, N3 and N4 are nitrogen atoms capable of protonation at physiological pH's; ;a and b may be the same or different and are integers from 1 to 4; ;A, B and C may be the same or different and are bridging groups which effectively maintain the distance between the nitrogen atoms such that the polyamines: ;(i) are capable of uptake by a target cell upon administration thereof to a human or non-human animal; and ;(ii) upon uptake by the target cell, competitively bind via an electrostatic interaction between the positively charged nitrogen atoms to substantially the same biological counter-anions as the intracellular natural polyamines in the target cell; ;the polyamines, upon binding to the biological counter-anion in the cell, function in a manner biologically different than the intracellular polyamines, the polyamines not occurring in nature; as well as pharmaceutical compositions embodying the polyamines and methods of treating patients requiring anti-neoplastic therapy.
机译:分子式为: <图像文件=“ US20030100615A1-20030529-C00001.GIF” he =“ 36.9684” id =“ EMI-C00001” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 184.3317“ /> 化学chemdraw文件 化学mol文件 ;或其与可药用酸的盐,其中:; R 1 -R 6 可以相同或不同的是烷基,芳基,芳基烷基,环烷基,任选地具有被至少一个醚性氧原子间断的烷基链或氢; ; N 1 ,N 2 ,N 3 和N 4 是能够在生理pH值下质子化的氮原子; ; a和b可以相同或不同,并且是1到4的整数; ; A,B和C可以相同或不同,并且是能有效维持氮原子之间距离的桥连基团,从而使多胺:(i)在施用于人或非人的靶细胞后能够被靶细胞摄取-人类动物; (ii)被靶细胞摄取后,通过带正电荷的氮原子之间的静电相互作用竞争性地结合到与靶细胞中细胞内天然多胺基本相同的生物抗衡阴离子上; ;多胺与细胞中的生物抗衡阴离子结合后,其生物学功能不同于细胞内多胺,自然界中不存在多胺。以及体现多胺的药物组合物以及需要抗肿瘤治疗的患者的治疗方法。

著录项

  • 公开/公告号US2003100615A1

    专利类型

  • 公开/公告日2003-05-29

    原文格式PDF

  • 申请/专利权人 BERGERON RAYMOND J.;

    申请/专利号US20020233400

  • 发明设计人 RAYMOND J. BERGERON;

    申请日2002-09-04

  • 分类号A61K31/137;A61K31/13;

  • 国家 US

  • 入库时间 2022-08-22 00:09:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号